Podcasts about circulating

Most people hear "cancer" and immediately hear "death sentence," then hand their body over to a protocol that shrinks the mass without ever asking why the mass showed up in the first place. Dr. Michael Karlfeldt has spent nearly four decades in integrative oncology. He explains the concept that reframed how I think about the cancer terrain. Your cells produce cancer every single day. Whether those cells take hold depends on your toxic burden, mitochondria, hormones, and immune function.  He shares how heavy metals stall energy production, why cancer stem cells survive conventional treatment, and what happens inside a clinic that stacks photodynamic therapy, ozone, and blood filtration on the same day. We also get into areas that almost nobody addresses: stored trauma, generational patterns, and spiritual connection.    "The best cancer is the one you never get." ~ Dr. Michael Karlfeldt   In This Episode: - Introduction: why Dr. Michael moved into integrative oncology - Removing the fear surrounding cancer diagnoses - Shifting the terrain that drives cancer - How heavy metals and chemicals contribute to cancer - Xenohormones and hormone-driven cancers - Circulating tumor cells vs. cancer stem cells - Repurposed drugs and blocking cancer pathways - Dr. Michael's protocols for addressing cancer - What is EBOO and what are its benefits? - Addressing spike proteins and vaccine-related cancers - The spiritual component of cancer and stored trauma - A message of hope for the newly diagnosed   Products & Resources Mentioned: Dr. Michael Karlfeldt's Book, A Better Way to Treat Cancer: Get your copy at https://a.co/d/05ZhWRNn  Bon Charge Red Light Face Mask: Get 15% off sitewide, plus free shipping and a 12-month warranty, with code WENDY at https://boncharge.com/   Tru Energy Skincare Bio Adaptive Hydration Oil: Try the oil and save up to $197 at https://trytruenergy.com/wendy5   Heavy Metals Quiz: Take the quiz at https://heavymetalsquiz.com    About Dr. Michael Karlfeldt:  Michael Karlfeldt, ND, PhD, is a board-certified naturopathic doctor with nearly four decades of clinical practice. He founded and directs The Karlfeldt Center. Motivated by the loss of his father to colon cancer, Dr. Karlfeldt has dedicated his career to developing restorative, non-toxic cancer protocols that integrate metabolic, genetic, and nutritional approaches with targeted oxidative therapies. He is the author of the Amazon bestseller A Better Way To Treat Cancer and recently co-wrote Breast Cancer Breakthrough with Dr. Veronique Desaulniers. He hosts the television series True Health: Body, Mind, & Spirit and three internationally recognized podcasts: Integrative Cancer Solutions, Integrative Lyme Solutions, and The Dr. K Show. Learn more about his work at https://www.thekarlfeldtcenter.com     Disclaimer The Myers Detox Podcast was created and hosted by Dr. Wendy Myers. This podcast is for information purposes only. Statements and views expressed on this podcast are not medical advice. This podcast, including Wendy Myers and the producers, disclaims responsibility for any possible adverse effects from using the information contained herein. The opinions of guests are their own, and this podcast does not endorse or accept responsibility for statements made by guests. This podcast does not make any representations or warranties about guests' qualifications or credibility. Individuals on this podcast may have a direct or indirect financial interest in products or services referred to herein. If you think you have a medical problem, consult a licensed physician.

A million bucks for a girl? Talk about 99 problems. It's Circulating the Tapes, the MST3K Watchalong Podcast on the Aewchcast. On this episode, Aewch thinks he had a better high school experience, but not by much, as he reviews High School Big Shot.Watch High School Big Shot Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfBeyond AtlantisAngels RevengeThe StarfightersTeenage StranglerSocial Media: @JustAewch 

I mean, there's technically fishmen, but not in the way you think. It's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this Episode, Aewch has no idea if pearl farming is self-sustainable, as he reviews Beyond Atlantis.Watch Beyond Atlantis Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch

Reinventing the motorcycle, it's Circulating the Tapes, the MST3K Watchalong podcast on The Aewchcast. On this episode, Aewch sells season passes for the meets, as he reviews The Sidehackers.Watch The Sidehackers Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch 

Completely lacking in Sir Killalot, it's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch lets the wars begin, as he reviews Robot Wars.Watch Robot Wars Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch

Love the podcast? Send us a text!What if a blood test could detect signs of breast cancer at the molecular level?Circulating tumor DNA, or ctDNA, is generating growing interest among people diagnosed with breast cancer, particularly those wondering about recurrence, treatment response, and what may be happening in the body before something appears on conventional imaging.One test you may have heard about is Signatera.In this episode of Breast Cancer Conversations, Laura Carfang talks with Shannon and Erin, two women with very different breast cancer experiences who both pursued Signatera testing.Erin was diagnosed with triple-negative breast cancer before her 35th birthday and began exploring Signatera after completing treatment and wondering how she would know if her cancer returned. Shannon was initially diagnosed with DCIS, later developed invasive disease, and is now living with oligometastatic stage IV breast cancer. Her Signatera results became one piece of a much larger diagnostic and monitoring picture.Together, they share the questions, emotions, uncertainty, and conversations with their healthcare teams that came with pursuing ctDNA testing.In this episode:What circulating tumor DNA (ctDNA) isWhat the Signatera test is designed to detectWhy some breast cancer patients are asking about ctDNA testingErin's experience asking her oncologist for Signatera testingShannon's experience with changing Signatera resultsWhat can happen when blood test results and imaging don't seem to tell the same storyRecurrence anxiety and the desire for more informationAdvocating for yourself while still partnering with your medical teamWhat it means to live with oligometastatic breast cancerThe emotional impact of waiting for test resultsThe questions that remain as ctDNA testing continues to evolveThis episode isn't about telling you whether you should—or shouldn't—get Signatera. It's an honest conversation about why patients are interested in this technology, what two women experienced when they pursued it, and why understanding both the possibilities and limitations of emerging testing matters.Important: The experiences shared in this episode are personal stories and should not be interpreted as medical advice. Talk with your oncology team about whether ctDNA testing is appropriate for your individual diagnosis and treatment plan.Support the showListener FeedbackIf this episode resonated with you, we invite you to leave a review on Apple Podcasts or Spotify.You can also click the link in the show notes that says "Love this episode? Send us a text" to share feedback.Messages are completely anonymous.If you would like us to follow up directly, please include your email address in your message so we can respond.Latest News: Join our Mailing List - New content drops every Monday! Discover FREE programs, support groups, and resources from SurvivingBReastCancer.org! Become a Breast Cancer Conversations+ Member! Sign Up Now. Enjoying our content? Please consider supporting our work. 

With more than 30 years of experience, Grammy nominated, mastering engineer, Joe Carra, is the chief engineer at Crystal Mastering. He joins the pod to talk about the history, the present, and the future of the audio world. He dives into his Dolby Atmos setup and tips for managing such a stacked roster of musicians. As a mastering engineer, he has a unique perch, working on thousands of songs per year. So it's great to hear his take on the whole thing and where this crazy industry is headed.For 30% off your first year of DistroKid to share your music with the world click ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠DistroKid.com/vip/lovemusicmore⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response. Author Ben Ho Park, MD, PhD, of the Vanderbilt-Ingram Cancer Center discusses current evidence regarding use of liquid biopsies in management of cancer with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Liquid Biopsies for Cancer Applications of Liquid Biopsy for Surgical Patients With Cancer

Talk about being haunted by the memories, It's Circulating the Tapes, The MST3K Watchalong Podcast on the Aewchcast. On this episode, Aewch starts charging admission for the lighthouse, as he reviews Tormented.Watch Tormented Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch

With all the excitement of the bearded lady without an act, it's Circulating the Tapes, the MST3K watchalong podcast on the Aewchcast. On this episode, Aewch lost a lot of money on the ring toss, as he reviews Carnival Magic.Watch Carnival Magic Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch

Featuring perspectives from Dr Joshua K Sabari, including the following topics: Jänne PA et al. Final analysis results and patient-reported outcomes from DESTINY-Lung02 — A dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic NSCLC. J Thorac Oncol 2025;20(12):1814-28. (0:00) Heymach JV et al. Circulating tumor DNA (ctDNA) analysis following zongertinib treatment (tx) in patients (pts) with human epidermal growth factor receptor 2 (HER2)-mutant non-small cell lung cancer (NSCLC): Phase Ia/Ib Beamion LUNG-1 study. ESMO 2025;Abstract 2020P. (8:30) Schram AM et al. Beamion PANTUMOR-1: Rationale and design of a phase II trial of zongertinib in HER2-overexpressed/amplified or HER2-mutant solid tumors. Future Oncol 2026;22(7):795-803. (12:53) Johnson ML et al. Beamion LUNG-2: A phase III randomized controlled trial of zongertinib (BI 1810631) versus standard of care in patients with locally advanced/metastatic non-squamous NSCLC harboring HER2 tyrosine kinase domain (TKD) mutations. ASCO 2024;Abstract TPS8654. (19:40) Le X et al. SOHO-02: Phase III trial of BAY 2927088 in patients with locally advanced or metastatic NSCLC with HER2-activating mutations. ASCO 2025;Abstract TPS8648. (21:41) Li BT et al. Open-label, randomized, multicenter, phase 3 study evaluating trastuzumab deruxtecan (T-DXd) as first-line treatment in patients with unresectable, locally advanced, or metastatic non-small cell lung cancer (NSCLC) harboring HER2 exon 19 or 20 mutations (DESTINY-Lung04). ASCO 2022;Abstract TPS9137. (22:59) Jänne PA et al. Trastuzumab deruxtecan for ERBB2-mutant metastatic NSCLC with or without brain metastases: A secondary analysis of randomized clinical trials. JAMA Netw Open 2025;8(11):e2543107. (24:37) CME information and select publications

Sarah Firman explores how dietary management can rapidly reduce phytanic acid levels in adult Refsum disease. This case series shows why adequate energy and carbohydrate intake, and avoiding weight loss and catabolism, matter alongside phytanic acid restriction. Adult Refsum Disease: Case Series of Reducing Circulating Phytanic Acid Levels With Dietary Interventions Sarah J. Firman, et al https://doi.org/10.1002/jmd2.70048

Aduana Clan of Asomgya and members of the Christo Asafo Mission have urged the public to disregard funeral dates circulating on social media for the late Apostle Dr. Kwadwo Safo, describing them as false and unauthorized

I hope you're not sick of pantaloons yet! It's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch needs a mana potion for this one, as he reviews Deathstalker and the Warriors From Hell!Watch Deathstalker and the Warriors From Hell Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch

Mike Mulligan and David Haugh continue to discuss the top six sports stories of the day in the Pick 6 segment

Circulating tumor DNA (ctDNA), a minimally invasive blood-based biomarker, has emerged as one of the most promising advances in cancer surveillance. Today, we will explore how ctDNA is transforming the management of colorectal cancer and anal squamous cell cancer across the disease continuum—from risk stratification and adjuvant therapy decision-making to surveillance and early detection of recurrence. Through landmark clinical trials, real-world applications, and emerging research, we will examine how ctDNA is helping move cancer care closer to the goal of truly personalized medicine.Hosts: ·       Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center·       Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian·       Dr. Philip Bauer, Assistant Professor of Surgery, Division of Colon and Rectal Surgery, The Ohio State University Wexner Medical Center, Arthur G. James Cancer Hospital·       Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer CenterGuests:Dr. Paul Romessor ·      Director of Colorectal and Anal Cancer, Department of Radiation Oncology·      Associate Attending Radiation OncologistMemorial Sloan Kettering Cancer CenterDr. Jeanne Tie ·      Medical Oncologist | Lower GI Unit ·      Lower GI Research Lead ·      Chair | Lower GI Working Party | GI Cancer TrialsPeter MacCallum Cancer Centre Dr. Takayuki Yoshino·      Professor, Global Center of Research Excellence for Advanced Medicine (G-CORE),Keio University School of Medicine·      Executive Advisor to Hospital East Director·      Director, Department of Global Oncology·      Chief, Department of Gastrointestinal OncologyNational Cancer Center Hospital EastLearning Objectives:·      Describe the biological basis and clinical applications of circulating tumor DNA (ctDNA) as a biomarker of minimal residual disease (MRD) in colorectal cancer.·      Interpret the prognostic significance of postoperative and longitudinal ctDNA testing and its role in predicting recurrence risk across stages of colorectal cancer.·      Evaluate evidence from landmark clinical trials, including DYNAMIC and GALAXY, supporting ctDNA-guided treatment de-escalation and escalation strategies in colorectal cancer.·      Discuss emerging applications of ctDNA monitoring in personalized cancer care, including surveillance, treatment response assessment, and future clinical trial directions. References:·      Ando, K. et al. (2026). Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study. Annals of Surgery. https://pubmed.ncbi.nlm.nih.gov/39854721/ (Note: If direct access is limited, the article is available via PMC: PMC12695342)·      Romesser, P. B. et al. (2026). Tumor-informed circulating tumor DNA stratifies recurrence risk and survival in anal squamous cell carcinoma. Nature Communications. https://pubmed.ncbi.nlm.nih.gov/38347209/·      Tie, J. et al. (2025). Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial. Nature Medicine. https://pubmed.ncbi.nlm.nih.gov/39943485/·      Tie, J. et al. (2025). Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial. Nature Medicine. https://pubmed.ncbi.nlm.nih.gov/39974258/Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Did you let the Tank Dell video get you..?!

Wasn't Archimedes that Owl in The Sword and The Stone? It's Circulating the Tapes, the MST3K watchalong Podcast on The Aewchcast. On this episode, Aewch has seen more action in a Final Fantasy game than today's movie, as he reviews Quest of the Delta Knights!Watch Quest of the Delta Knights Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Kind of like a high school memory, it wasn't that good of a time, It's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch wonders what the diner pays for an hour, as he reviews The Girl in Lovers Lane!Watch The Girl in Lovers Lane Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

More depressing than a Yakov Smirnoff bit, it's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch gets warmed up for some Cold War, as he reviews Rocket Attack U.S.A.! Watch Rocket Attack U.S.A. Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Beach front property right next to the rocket test site? Sign me up! It's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch wonders how an inflatable pool toy can communicate with kids, as he reviews The Space Children!Watch The Space Children Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Hide your milk bottles, it's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch relates to the main character (Except for the whole “hypnosis” thing) as he reviews I was a Teenage Werewolf!Watch I Was a Teenage Werewolf Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be offered—including scenarios where tissue biopsies are challenging, unsafe, or unavailable in time to guide management—and explicitly outline situations where testing should not be utilized. They dive into the evidence evaluating ctDNA for treatment selection, molecular residual disease (MRD), and response monitoring across solid tumors and lymphoma. Drs. Lockwood and Gray explain the importance of balancing ctDNA's high specificity with its moderate sensitivity. They also touch on outstanding questions, including standardizing definitions for MRD, disease-specific applications, and the use of multi-cancer early detection (MCED) screening.  Read the full guideline, "Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline" at www.asco.org/molecular-testing-and-biomarkers-guidelines" LINK TO FULL TRANSCRIPT

Opponents of the Shady Grove redevelopment plan recently approved by city leadership are getting serious, and getting organized - Circulating petitions to force a referendum vote on the issue (at 14:48) --- Adulting is hard - And one of the hardest parts also may be one of the most unexpected... Young adults trying to figure out how to navigate the healthcare system for the first time (at 28:22) --- Around Town: Live music, great food and more... The second annual VetFest is a day-long community celebration of and for all those who have served (at 47:49)

The franchise with less brand power than GoBots! It's Circulating the Tapes, the MST3K watchalong podcast on The Aewchcast. On this episode, Aewch finds a movie that makes Kaiju Big Battel look like Shakespeare, as he reviews Atlantic Rim.Watch Atlantic Rim Right Here! The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Featuring perspectives from Prof Thomas Powles, including the following topics: Circulating tumor DNA (ctDNA) analyses with adjuvant nivolumab for MIBC in the CheckMate 274 study (0:00) Use of ctDNA to guide response-adapted bladder preservation for patients with MIBC (2:27) ctDNA response-adapted treatment de-escalation for patients with metastatic urothelial carcinoma: The CT-READ trial (10:26) Emerging data and studies regarding urinary tumor DNA (18:04) CME information and select publications

The Praise O'Clock Show (also known as The Praiseworld Podcast) is the breakfast show of Praiseworld Radio.Host: Goodness Ezeh

The world is threatened by tiny shrimp! It's Circulating the Tapes, the MST3K watchalong podcast on the Aewchcast. On this episode, Aewch never reuses a costume as he reviews Night of the Blood Beast. Plus, see what happens when you bring a phone into the bedroom, with the short Once Upon a Honeymoon.Watch Night of the Blood Beast Right Here!The CTT UERL Top 10! I Accuse My ParentsGodzilla vs MegalonMaster Ninja 1Santa Claus Conquers the MartiansAvalancheWerewolfAngels RevengeThe StarfightersTeenage StranglerMerlin's Shop of Mystical WondersSocial Media: @JustAewch Email: aewch64@gmail.com

Interview conducted on March 11, 2026, by Dr Neil Love, including the following topics: Circulating tumor DNA (ctDNA)-guided adjuvant therapy with atezolizumab for muscle-invasive bladder cancer (MIBC) (0:00) Use of ctDNA in guiding systemic treatment selection for patients with urothelial bladder cancer (10:03) ctDNA analyses with perioperative durvalumab for MIBC in the Phase III NIAGARA study (16:51) New research advances in the monitoring and management of urothelial bladder cancer (22:21) CME information and select publications  

As cancer vaccines move into Phase II and III clinical trials, it isincreasingly important for surgeons to understand their role in thisevolving landscape. What exactly are these vaccines, how do they work,and what should the surgical community know about theirimplementation? Join BTK surgical education fellows Kara Button andMichelle LaBella as they sit down with Professor Robert Jones to breakdown the science of mRNA vaccines, the logistics of tissueprocurement, and the future of cancer care.Hosts:- Professor Robert Jones: Consultant Liver Surgeon, Liverpool UniversityHospitals; UK National Institute for Healthcare Research, Co-Lead forthe Cancer Vaccine Innovation Pathway, Bowel Cancer UK and RoyalCollege of Surgeons UK Lead for Research into Advanced Bowel Cancer,and UK Chief Investigator for the BNT122-01 trial.https://www.linkedin.com/in/robert-jones-6103722a/- Kara Button, DO: General Surgery Resident, Maine Medical Center;Behind the Knife Surgical Education Fellow.- Michelle LaBella, MD: General Surgery Resident; University of NorthCarolina; Behind the Knife Surgical Education Fellow.References:https://clinicaltrials.biontech.com/trials/BNT122-01Jones RP, Lee LYW, Corrie PG, et al. Individualized cancer vaccinesversus surveillance after adjuvant chemotherapy for surgicallyresected high-risk stage 2 and stage 3 colorectal cancer: protocol fora randomized trial. BJS. 2023;110(12):1883-1884.doi:10.1093/bjs/znad332https://pubmed.ncbi.nlm.nih.gov/37856683/Tie J, Wang Y, Loree JM, et al. Circulating tumor DNA-guided adjuvanttherapy in locally advanced colon cancer: the randomized phase 2/3DYNAMIC-III trial. Nat Med. 2025;31(12):4291-4300.doi:10.1038/s41591-025-04030-whttps://pubmed.ncbi.nlm.nih.gov/41115959/Rojas LA, Sethna Z, Soares KC, et al. Personalized RNA neoantigenvaccines stimulate T cells in pancreatic cancer. Nature.2023;618(7963):144-150. doi:10.1038/s41586-023-06063-yhttps://pubmed.ncbi.nlm.nih.gov/37165196/https://www.cancer.ox.ac.uk/research/lynchvax#:~:text=The%20LynchVax%20program%2C%20funded%20by,individuals%20with%20this%20genetic%20conditionPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Circulating your sexual energy might sound a bit out there… but this is one of the most powerful things you can learn as a man.Most guys experience sex as a build-up → release → depletion cycle. A few minutes of pleasure… then it's over, and the energy is gone.But when you learn how to circulate that energy instead of just releasing it, everything changes.You can experience full-body orgasms, sustain arousal without losing control, and actually build energy through sex instead of draining yourself.In this video, I go deep into what it really means to circulate sexual energy — not just the beginner-level “breathe it up and down” stuff, but the deeper principles that actually make this work.In this video you'll learn:• What sexual energy actually is (beyond just arousal)• Why most men feel drained after sex• How to redirect sexual energy through your body• The role of the microcosmic orbit and energy channels• Why force-based techniques don't work long-term• How to develop real sensitivity to your body and energy• The shift from mechanical technique → embodied awarenessGet my FREE Ebook - 3 Techniques for Legendary Ejaculation Control:

In this video, Dr. Ruscio discusses the benefits of glutathione, the body's master antioxidant. He discusses how to boost glutathione naturally via the diet, supplements that help boost glutathione, and how to supplement with glutathione directly (including the best forms and doses of glutathione).   ✅ Start healing with us! Learn more about our virtual clinic:  https://drruscio.com/virtual-clinic/  

In the final episode of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the study results and their implications for improving clinical practice.  Read more about this abstract on the AAN website. 

Circulating around the internet right now, is the bold claim that Israel is bombing Christian villages in Lebanon. The insinuation is that Israel is purposely targeting Christians, because Israel has a particular hatred for anything Christian in the Middle East. And as odd as it might sound, it's actually true. At least the bombing part is. The reason though? Very different from what people are claiming. Also it looks like Israel has eliminated 1,800 Hezbollah terrorists in Lebanon, which is incredible.  Justin Hilton Breaks it down for you here on today's show.  Get your Exist t-shirt here: https://israelguys.link/shirt-86ex929qn  Join our Members Group! https://israelguys.link/donate-86ex929h6  Sign up for the Prophets of Israel Daily: https://thelandofisrael.com/prophets-of-israel/ Sign up for The Israel Guys Show Notes: https://theisraelguys.com/subscribe/ Follow The Israel Guys on X: https://x.com/theisraelguys Join our Telegram channel: https://t.me/theisraelguys #Israelnews #Hezbollah #Lebanon #Iranwar #Trump #Bibi #Americannews #Ceasefire  

In part two of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss how this technology was developed and how it has evolved.  Read more about this abstract on the AAN website. 

Featuring an interview with Dr Natalie Vokes, including the following topics: Perioperative minimal residual disease (MRD) detected by circulating tumor DNA (ctDNA) testing in patients with lung cancer (0:00) Ohara S et al. Clinical significance of perioperative MRD detected by ctDNA in patients with lung cancer with a long follow-up data: An exploratory study. JTO Clin Res Rep 2024;6(3):100762. Abstract Masuda K et al. MRDSEEKER (JCOG2111A): A prospective study to evaluate MRD and its association with prognosis in curative-intent NSCLC. World Conference on Lung Cancer 2025;Abstract P3.18.04.  Zhou C et al. IMpower010: Biomarkers of disease-free survival in a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy in stage IB-IIIA NSCLC. ESMO IO 2021;Abstract 2O. MRD analysis of adjuvant therapy with osimertinib for resected EGFR-mutated Stage IB to IIIA non-small cell lung cancer (NSCLC) (8:28) Herbst RS et al. Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer. Nat Med 2025;31(6):1958-68. Abstract MRD analyses of perioperative chemoimmunotherapy for resected NSCLC (15:12) Forde PM et al. Overall survival with neoadjuvant nivolumab plus chemotherapy in lung cancer. N Engl J Med 2025;393(8):741-52. Abstract  ctDNA dynamics in advanced NSCLC treated with immunotherapy (20:56) Vokes NI et al. Circulating tumor DNA (ctDNA) dynamics and survival outcomes in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and high (>50%) programmed cell death ligand 1 (PD-L1) expression, randomized to cemiplimab (cemi) vs chemotherapy (chemo). ASCO 2023;Abstract 9022. Anagnostou V et al. ctDNA response after pembrolizumab in non-small cell lung cancer: Phase 2 adaptive trial results. Nat Med 2023;29(10):2559-69. Abstract Anagnostou V et al. A biomarker-directed, multi-center phase II/III study of ctDNA molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer (BR.36). ASCO 2025;Abstract TPS8669. CME information and select publications

In the first part of this series, Dr. Justin Abbatemarco and Dr. Shreya Louis discuss the background and evolving terminology around circulating tumor DNA, cell‑free DNA and CSF‑based testing in neurology.  Read more about this abstract on the AAN website. 

Love doesn't arrive from a distance; it circulates in here. You're attached. You're connected. Help is here. WATCH. LISTEN. READ. KNOW. LOVE.

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 602.585.9800More HMS: holmbergpodcast.com, 98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Guest: Padraic Scanlan. Scanlan details the volatility in the Irish countryside, the use of coercion acts, and the lack of circulating cash as evidence of uncivilization.1847 EIRE